UTMD vs. DHR
UTMD (Utah Medical Products, Inc.) and DHR (Danaher Corporation) are both stocks. Both are in the Healthcare sector — UTMD in Medical Instruments & Supplies, DHR in Diagnostics & Research. Over the past 10 years, UTMD returned 2.17%/yr vs 11.38%/yr for DHR. At a 0.17 correlation, their price movements are largely independent.
Performance
UTMD vs. DHR - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, UTMD achieves a 26.30% return, which is significantly higher than DHR's -12.20% return. Over the past 10 years, UTMD has underperformed DHR with an annualized return of 2.17%, while DHR has yielded a comparatively higher 11.38% annualized return.
UTMD
- 1D
- 3.02%
- 1M
- 3.68%
- 6M
- 18.03%
- YTD
- 26.30%
- 1Y
- 26.54%
- 3Y*
- -9.16%
- 5Y*
- -2.02%
- 10Y*
- 2.17%
DHR
- 1D
- 0.56%
- 1M
- 11.37%
- 6M
- -15.90%
- YTD
- -12.20%
- 1Y
- -1.57%
- 3Y*
- -1.52%
- 5Y*
- -3.47%
- 10Y*
- 11.38%
UTMD vs. DHR - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
UTMD Utah Medical Products, Inc. | 26.30% | -7.01% | -25.69% | -15.10% | 1.87% | 21.97% | -20.87% | 31.46% | 3.24% | 13.59% |
DHR Danaher Corporation | -12.20% | 0.35% | -0.35% | -1.22% | -19.02% | 48.57% | 45.34% | 49.55% | 11.80% | 20.01% |
Correlation
The correlation between UTMD and DHR is 0.31, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.31 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.26 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.28 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.24 |
Correlation (All Time) Calculated using the full available price history since Mar 8, 1999 | 0.17 |
The correlation between UTMD and DHR shifts across timeframes, from 0.17 (all time) to 0.31 (1 year), reflecting how their relationship changes across market environments.
Fundamentals
UTMD:
$222.91M
DHR:
$141.67B
UTMD:
$3.39
DHR:
$5.18
UTMD:
20.63
DHR:
38.63
UTMD:
5.96
DHR:
5.75
UTMD:
1.85
DHR:
2.69
UTMD:
$37.53M
DHR:
$24.78B
UTMD:
$20.13M
DHR:
$15.04B
UTMD:
$15.06M
DHR:
$6.69B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
UTMD vs. DHR — Risk / Return Rank
UTMD
DHR
UTMD vs. DHR - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Utah Medical Products, Inc. (UTMD) and Danaher Corporation (DHR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| UTMD | DHR | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.03 | ||
| Sortino ratioReturn per unit of downside risk | +1.48 | ||
| Omega ratioGain probability vs. loss probability | 1.19 | 1.02 | +0.17 |
| Calmar ratioReturn relative to maximum drawdown | 1.69 | -0.05 | +1.74 |
| Martin ratioReturn relative to average drawdown | 4.05 | -0.10 | +4.16 |
Loading charts...
Drawdowns
UTMD vs. DHR - Drawdown Comparison
The maximum UTMD drawdown since its inception was -55.58%, which is greater than DHR's maximum drawdown of -45.80%. Use the drawdown chart below to compare losses from any high point for UTMD and DHR.
Loading charts...
Drawdown Indicators
| UTMD | DHR | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -55.58% | -45.80% | -9.78% |
Max Drawdown (1Y)Largest decline over 1 year | -15.77% | -32.97% | +17.20% |
Max Drawdown (3Y)Largest decline over 3 years | -46.20% | -41.72% | -4.48% |
Max Drawdown (5Y)Largest decline over 5 years | -55.58% | -43.81% | -11.77% |
Max Drawdown (10Y)Largest decline over 10 years | -55.58% | -43.81% | -11.77% |
Current DrawdownCurrent decline from peak | -38.37% | -30.39% | -7.98% |
Average DrawdownAverage peak-to-trough decline | -15.17% | -10.27% | -4.90% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.57% | 15.05% | -8.48% |
Volatility
UTMD vs. DHR - Volatility Comparison
Utah Medical Products, Inc. (UTMD) has a higher volatility of 15.28% compared to Danaher Corporation (DHR) at 8.64%. This indicates that UTMD's price experiences larger fluctuations and is considered to be riskier than DHR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| UTMD | DHR | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 15.28% | 8.64% | +6.64% |
Volatility (6M)Calculated over the trailing 6-month period | 21.43% | 20.83% | +0.60% |
Volatility (1Y)Calculated over the trailing 1-year period | 27.46% | 29.00% | -1.54% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 28.40% | 28.16% | +0.24% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 30.90% | 25.64% | +5.26% |
Dividends
UTMD vs. DHR - Dividend Comparison
UTMD's dividend yield for the trailing twelve months is around 1.76%, more than DHR's 0.72% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
DHR Danaher Corporation | 0.72% | 0.56% | 0.47% | 12.64% | 0.38% | 0.26% | 0.32% | 0.44% | 0.62% | 0.60% | 32.55% | 0.58% |
UTMD Utah Medical Products, Inc. | 1.76% | 2.19% | 1.96% | 1.41% | 1.16% | 2.86% | 1.33% | 1.02% | 1.31% | 1.31% | 1.44% | 1.75% |
Financials
UTMD vs. DHR - Financials Comparison
This section allows you to compare key financial metrics between Utah Medical Products, Inc. and Danaher Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
UTMD vs. DHR - Profitability Comparison
UTMD - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Utah Medical Products, Inc. reported a gross profit of 5.28M and revenue of 8.72M. Therefore, the gross margin over that period was 60.6%.
DHR - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Danaher Corporation reported a gross profit of 3.59B and revenue of 5.95B. Therefore, the gross margin over that period was 60.3%.
UTMD - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Utah Medical Products, Inc. reported an operating income of 2.57M and revenue of 8.72M, resulting in an operating margin of 29.4%.
DHR - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Danaher Corporation reported an operating income of 1.34B and revenue of 5.95B, resulting in an operating margin of 22.6%.
UTMD - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Utah Medical Products, Inc. reported a net income of 2.60M and revenue of 8.72M, resulting in a net margin of 29.9%.
DHR - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Danaher Corporation reported a net income of 1.03B and revenue of 5.95B, resulting in a net margin of 17.3%.
Frequently Asked Questions
UTMD and DHR have a correlation of 0.31, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
UTMD has higher volatility (15.28%) compared to DHR (8.64%). In terms of maximum drawdown, UTMD dropped -55.58% vs DHR's -45.80%.
UTMD currently has the higher Sharpe Ratio (0.97 vs -0.05), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for UTMD and DHR
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer